Ad is loading...
CYTK
Price
$49.86
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
91 days until earnings call
IOVA
Price
$8.14
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
97 days until earnings call
Ad is loading...

CYTK vs IOVA

Header iconCYTK vs IOVA Comparison
Open Charts CYTK vs IOVABanner chart's image
Cytokinetics
Price$49.86
Change-$0.00 (-0.00%)
Volume$1.57M
CapitalizationN/A
Iovance Biotherapeutics
Price$8.14
Change-$0.00 (-0.00%)
Volume$6.01M
CapitalizationN/A
CYTK vs IOVA Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CYTK vs. IOVA commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Sell and IOVA is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (CYTK: $49.86 vs. IOVA: $8.14)
Brand notoriety: CYTK and IOVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 87% vs. IOVA: 96%
Market capitalization -- CYTK: $5.88B vs. IOVA: $2.48B
CYTK [@Biotechnology] is valued at $5.88B. IOVA’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $458.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileIOVA’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • IOVA’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than IOVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while IOVA’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 7 bearish.
  • IOVA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IOVA is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -10.90% price change this week, while IOVA (@Biotechnology) price change was -9.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.72%. For the same industry, the average monthly price growth was -7.79%, and the average quarterly price growth was +1.74%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 20, 2025.

IOVA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-3.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.88B) has a higher market cap than IOVA($2.48B). IOVA YTD gains are higher at: 0.123 vs. CYTK (-40.280). IOVA has higher annual earnings (EBITDA): -388.32M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. IOVA (397M). IOVA has less debt than CYTK: IOVA (78.9M) vs CYTK (790M). IOVA has higher revenues than CYTK: IOVA (90.9M) vs CYTK (3.22M).
CYTKIOVACYTK / IOVA
Capitalization5.88B2.48B237%
EBITDA-481.94M-388.32M124%
Gain YTD-40.2800.123-32,747%
P/E RatioN/AN/A-
Revenue3.22M90.9M4%
Total Cash1.01B397M255%
Total Debt790M78.9M1,001%
FUNDAMENTALS RATINGS
CYTK vs IOVA: Fundamental Ratings
CYTK
IOVA
OUTLOOK RATING
1..100
7767
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (49) in the Biotechnology industry is somewhat better than the same rating for CYTK (100). This means that IOVA’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for IOVA (100). This means that CYTK’s stock grew somewhat faster than IOVA’s over the last 12 months.

IOVA's SMR Rating (97) in the Biotechnology industry is in the same range as CYTK (100). This means that IOVA’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (52) in the Biotechnology industry is in the same range as IOVA (64). This means that CYTK’s stock grew similarly to IOVA’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for IOVA (100). This means that CYTK’s stock grew significantly faster than IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKIOVA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IOVA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ILVBX15.440.08
+0.52%
Columbia Integrated Large Cap Val A
VMSGX21.310.07
+0.33%
VALIC Company I Mid Cap Strategic Gr
TBDCX13.90N/A
N/A
PGIM Jennison Diversified Growth C
MEIGX52.82-0.06
-0.11%
MFS Value R1
DFITX3.63-0.03
-0.82%
DFA International Real Estate Sec I

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-2.41%
KRON - CYTK
43%
Loosely correlated
+1.18%
IOVA - CYTK
42%
Loosely correlated
-0.61%
DARE - CYTK
42%
Loosely correlated
N/A
CKPT - CYTK
41%
Loosely correlated
N/A
DSGN - CYTK
40%
Loosely correlated
N/A
More

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with CRSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-0.61%
CRSP - IOVA
47%
Loosely correlated
+0.62%
BEAM - IOVA
45%
Loosely correlated
-3.16%
VCYT - IOVA
43%
Loosely correlated
+0.13%
CYTK - IOVA
42%
Loosely correlated
-2.41%
AKRO - IOVA
42%
Loosely correlated
-1.27%
More